D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 52,147 437 World Ranking 6019 National Ranking 3337

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

John S. Bradley spends much of his time researching Internal medicine, Surgery, Intensive care medicine, Streptococcus pneumoniae and Meningitis. His studies deal with areas such as Bacteremia, Placebo and Gastroenterology as well as Internal medicine. His Intensive care medicine study combines topics from a wide range of disciplines, such as MEDLINE and Pulmonology.

His research investigates the connection between Streptococcus pneumoniae and topics such as Ceftriaxone that intersect with problems in Vancomycin. His Meningitis research includes themes of Randomization, Antibacterial agent and Immunology. His Alternative medicine research is multidisciplinary, incorporating perspectives in Drug development, Human services, Medical research and Call to action.

His most cited work include:

  • Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America (3371 citations)
  • Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America (3371 citations)
  • The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America (1173 citations)

What are the main themes of his work throughout his whole career to date?

John S. Bradley mainly investigates Internal medicine, Intensive care medicine, Pediatrics, Antibiotics and Surgery. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Streptococcus pneumoniae. In his study, which falls under the umbrella issue of Streptococcus pneumoniae, Immunology is strongly linked to Meningitis.

His Intensive care medicine research includes elements of Vancomycin, Antimicrobial, MEDLINE and Clinical trial. His work on Antibiotics deals in particular with Antibacterial agent and Antibiotic resistance. As part of one scientific family, John S. Bradley deals mainly with the area of Pharmacokinetics, narrowing it down to issues related to the Dosing, and often Pharmacodynamics.

He most often published in these fields:

  • Internal medicine (21.38%)
  • Intensive care medicine (18.55%)
  • Pediatrics (15.41%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (21.38%)
  • Malaria (7.39%)
  • Intensive care medicine (18.55%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Malaria, Intensive care medicine, Dosing and Plasmodium falciparum. John S. Bradley has researched Malaria in several fields, including Tropical medicine, Resistance and Environmental health. In his work, Cohort study is strongly intertwined with Odds ratio, which is a subfield of Environmental health.

His work is dedicated to discovering how Intensive care medicine, Vancomycin are connected with Methicillin-resistant Staphylococcus aureus and other disciplines. His Dosing research incorporates elements of Tobramycin, Aminoglycoside and Pharmacodynamics. His Gametocyte, Artemether/lumefantrine and Artemisinin study in the realm of Plasmodium falciparum connects with subjects such as Primaquine.

Between 2017 and 2021, his most popular works were:

  • Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa (247 citations)
  • Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa (247 citations)
  • Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists (133 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Antibiotics

Malaria, Internal medicine, Intensive care medicine, Dosing and Vancomycin are his primary areas of study. His study in Malaria is interdisciplinary in nature, drawing from both Tropical medicine, Socioeconomics and Environmental health. In his works, he undertakes multidisciplinary study on Environmental health and Context.

His Internal medicine study which covers Antibiotics that intersects with Bacteria, Gram and Precision medicine. The concepts of his Intensive care medicine study are interwoven with issues in Infectious disease, Ambulatory care, MEDLINE, Treatment outcome and Virus. In his study, Meningitis and Randomization is inextricably linked to Pharmacotherapy, which falls within the broad field of Vancomycin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Helen W. Boucher;George H. Talbot;John S. Bradley;John S. Bradley;John E. Edwards;John E. Edwards.
Clinical Infectious Diseases (2009)

5739 Citations

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

Brad Spellberg;Robert Guidos;David Gilbert;John Bradley;John Bradley.
Clinical Infectious Diseases (2008)

1925 Citations

Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

Joseph S. Solomkin;John E. Mazuski;John S. Bradley;Keith A. Rodvold.
Clinical Infectious Diseases (2010)

1508 Citations

Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

George H. Talbot;John Bradley;John Bradley;John E. Edwards;David Gilbert.
Clinical Infectious Diseases (2006)

1393 Citations

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

John S. Bradley;Carrie L. Byington;Samir S. Shah;Brian Alverson.
Clinical Infectious Diseases (2011)

890 Citations

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Kazuaki Nishijima;Yin-Shan Ng;Lichun Zhong;John Bradley.
American Journal of Pathology (2007)

863 Citations

Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America

Scott A. Harper;John S. Bradley;Janet A. Englund;Thomas M. File.
Clinical Infectious Diseases (2009)

817 Citations

10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

Helen W. Boucher;George H. Talbot;Daniel K. Benjamin;Daniel K. Benjamin;John Bradley;John Bradley.
Clinical Infectious Diseases (2013)

699 Citations

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Gerd R Burmester;Ricardo Blanco;Christina Charles-Schoeman;Jürgen Wollenhaupt.
The Lancet (2013)

691 Citations

Combating antimicrobial resistance: policy recommendations to save lives.

Spellberg B;Blaser M;Guidos Rj.
Clinical Infectious Diseases (2011)

688 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John S. Bradley

Teun Bousema

Teun Bousema

Radboud University Nijmegen

Publications: 101

Roger L. Nation

Roger L. Nation

Monash University

Publications: 79

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 78

Susanna Esposito

Susanna Esposito

University of Parma

Publications: 71

Holger Görg

Holger Görg

Kiel University

Publications: 68

Samir S. Shah

Samir S. Shah

Cincinnati Children's Hospital Medical Center

Publications: 60

Chris Drakeley

Chris Drakeley

University of London

Publications: 58

Sheldon L. Kaplan

Sheldon L. Kaplan

Baylor College of Medicine

Publications: 57

Bruno Chaudret

Bruno Chaudret

Laboratoire de Physique et Chimie des Nano-Objets

Publications: 56

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 54

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 53

Eric Strobl

Eric Strobl

University of Bern

Publications: 52

David L. Paterson

David L. Paterson

University of Queensland

Publications: 50

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 50

Ron Dagan

Ron Dagan

Ben-Gurion University of the Negev

Publications: 50

Jason A. Roberts

Jason A. Roberts

Royal Brisbane and Women's Hospital

Publications: 47

Trending Scientists

Alistair Moffat

Alistair Moffat

University of Melbourne

Leif Katsuo Oxenløwe

Leif Katsuo Oxenløwe

Technical University of Denmark

Amir Fam

Amir Fam

Queen's University

Zhiyong Liu

Zhiyong Liu

University of Science and Technology Beijing

Nuria Lopez-Bigas

Nuria Lopez-Bigas

Institució Catalana de Recerca i Estudis Avançats

I. Karen Temple

I. Karen Temple

University of Southampton

David Grunwald

David Grunwald

University of Utah

Kazuya Watanabe

Kazuya Watanabe

Tokyo University of Pharmacy and Life Sciences

Michael Baum

Michael Baum

International Center for Agricultural Research in the Dry Areas, Morocco

Gerald J. Spangrude

Gerald J. Spangrude

University of Utah

Andrew S. Ackerman

Andrew S. Ackerman

Goddard Institute for Space Studies

Mihály Hajós

Mihály Hajós

Yale University

Toshitaka Nabeshima

Toshitaka Nabeshima

Fujita Health University

Barbara A. Goff

Barbara A. Goff

University of Washington

Nikolaos Scarmeas

Nikolaos Scarmeas

National and Kapodistrian University of Athens

Jürgen Weitz

Jürgen Weitz

TU Dresden

Something went wrong. Please try again later.